SCAI Therapeutics
History
-
2019
- 06
- Founded
- 11
- Series A funding
- 12
- Certified as a venture company, and Registration of Research Center
-
2020
- 05
- Selected as one of Big 3 companies by Ministry of SMEs and Startups
-
2021
- 05
- Launching SCAI-HA in the market
- 07
- Series B funding
-
2022
- 05
- Launching SCAI-NaDC in the market
- 12
- IND approval for Phase 2 clinical trial of SCAI-001
-
2024
- 02
- Completion of Phase 2 clinical trial for SCAI-001
- 04
- Lunching SCAI-PDRN in the market
- 12
- Acquisition of A-STIN (M&A)
-
2025
- 04
- IND approval for Phase 1 clinical trial of SCAI-005
-
2026
- 05
- IND approval for Phase 2 clinical trial of SCAI-005
- 07
- Series C funding